Related Tags >> Takeda alogliptin Mannkind Amgen

FDA delay News

Most Popular FDA delay Story

FDA delays Amylin's Byetta LAR

March 15, 2010 — 8:21am ET | By Maureen Martino

Amylin, Eli Lilly and Alkermes have received an FDA complete response letter for Bydureon, but the companies note in an announcement that there are no requests for new pre-clinical or clinical Read more...

FDA delay Press Releases

Latest Headlines

MannKind's inhaled insulin drug Afrezza delayed
March 15, 2010
FDA delays Amylin's Byetta LAR
March 15, 2010
FDA puts Cadence pain drug app on hold
February 11, 2010
Incomplete plant inspections prevent Zuplenz approval
February 8, 2010
Mannkind hit with insulin inhaler delay
January 11, 2010
FDA hesitates on Cephalon's jet lag drug
December 22, 2009
FDA extends review for pain drug
November 20, 2009
FDA extends Cadence drug review
November 13, 2009
Transcept shares battered after FDA denies Intermezzo OK
October 29, 2009
Novartis hit with FDA delay on blockbuster COPD drug
October 19, 2009
Amgen shares sink as FDA delays D-mab approval
October 19, 2009
Is Amgen facing a significant delay on denosumab?
October 15, 2009
FDA expresses doubt about Repros' Proellex
September 29, 2009
In setback, FDA demands new work on SkyePharma's Flutiform
September 1, 2009
FDA delays approval of Wyeth's Prevnar-13
August 12, 2009
FDA wants more info on Novartis' Menveo vax
July 1, 2009
FDA throws up roadblock for Takeda's diabetes drug
June 29, 2009
Acura shares tank on forecasted FDA delay
June 24, 2009
Genmab shares slide on FDA delay
June 16, 2009
Decision delayed on United Therapeutics' Tyvaso
April 29, 2009

Paid Research Reports

More Research Reports >>

Free Newsletter

Most Popular Stories

Webinars

Hottest Products

Featured Jobs

Events